Insider trade

CFO sold ~$79K of HIMS shares in the open market

Traded Apr 6, 2026 · Filed Apr 7, 2026

Why it stands out

The money chief of Hims & Hers Health sold $79K of Hims & Hers Health shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CFO$25K–$100KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$79,409

Shares × reported transaction price

Timing vs results

42 days after results of Feb 23, 2026, 35 days before results of May 11, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+25.3%	+3.5%	+21.7%
30 days	+45.8%	+9.1%	+36.7%
90 days	+86.5%	+10.6%	+75.9%
180 days	+53.0%	+14.6%	+38.4%

Past results only. Not a forecast.

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.95-$20.02). The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Scheduled in advance6mo ago

6mo ago

Derivative exercise or conversion — not an open-market buy.

6mo ago

Derivative exercise or conversion — not an open-market buy.